Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hiv (26) 26
index medicus (24) 24
humans (22) 22
antiretroviral therapy (20) 20
female (20) 20
infectious diseases (20) 20
male (19) 19
children (18) 18
immunology (17) 17
child, preschool (16) 16
mortality (16) 16
child (15) 15
hiv infections - drug therapy (15) 15
human immunodeficiency virus--hiv (15) 15
africa (14) 14
infant (14) 14
aids/hiv (12) 12
drug therapy (11) 11
highly active antiretroviral therapy (10) 10
pediatrics (10) 10
acquired immune deficiency syndrome--aids (9) 9
analysis (9) 9
antiretroviral drugs (9) 9
morbidity (9) 9
research article (9) 9
adolescent (8) 8
antiviral agents (8) 8
cote d'ivoire (8) 8
hiv infection (8) 8
therapy (8) 8
health aspects (7) 7
prospective studies (7) 7
research (7) 7
west africa (7) 7
anti-hiv agents - therapeutic use (6) 6
anti-retroviral agents - therapeutic use (6) 6
care and treatment (6) 6
collaboration (6) 6
epidemiology (6) 6
medicine (6) 6
age (5) 5
antiretroviral agents (5) 5
article (5) 5
children & youth (5) 5
cotrimoxazole (5) 5
hiv infections - complications (5) 5
hiv infections - epidemiology (5) 5
human immunodeficiency virus (5) 5
infant, newborn (5) 5
infants (5) 5
microbiology (5) 5
patients (5) 5
prevalence (5) 5
prevention (5) 5
virology (5) 5
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (4) 4
[sdv]life sciences [q-bio] (4) 4
acquired immune deficiency syndrome (4) 4
adult (4) 4
africa, western - epidemiology (4) 4
aids (4) 4
biology and life sciences (4) 4
cohort studies (4) 4
cote-divoire (4) 4
diagnosis (4) 4
hiv-infected children (4) 4
incidence (4) 4
infections (4) 4
malnutrition (4) 4
medicine and health sciences (4) 4
middle aged (4) 4
outcomes (4) 4
people and places (4) 4
sub-saharan africa (4) 4
transmission (4) 4
tuberculosis (4) 4
young adult (4) 4
abidjan (3) 3
adolescents (3) 3
africa south of the sahara - epidemiology (3) 3
age groups (3) 3
anthropometry (3) 3
antiretroviral treatment (3) 3
cd4 lymphocyte count (3) 3
complications and side effects (3) 3
cost-effectiveness (3) 3
cote d'ivoire - epidemiology (3) 3
cross-sectional studies (3) 3
development and progression (3) 3
dosage and administration (3) 3
drug-resistance (3) 3
drugs (3) 3
growth (3) 3
hiv infection in children (3) 3
hiv infections - mortality (3) 3
hiv infections - virology (3) 3
hiv patients (3) 3
hiv-1-infected children (3) 3
immune reconstitution (3) 3
life sciences (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study
by Ekouevi, Didier K and Balestre, Eric and Coffie, Patrick A and Minta, Daouda and Messou, Eugene and Sawadogo, Adrien and Minga, Albert and Sow, Papa Salif and Bissagnene, Emmanuel and Eholie, Serge P and Gottlieb, Geoffrey S and Dabis, François and Zannou, Djimon Marcel and Ahouada, Carin and Akakpo, Jocelyn and Ahomadegbé, Christelle and Bashi, Jules and Gougounon-Houéto, Alice and Azon-Kouanou, Angèle and Houngbé, Fabien and Koumakpaï, Sikiratou and Alihonou, Florence and D'Almeida, Marcelline and Hodonou, Irvine and Hounhoui, Ghislaine and Sagbo, Gracien and Tossa-Bagnan, Leïla and Adjide, Herman and Drabo, Joseph and Bognounou, René and Dienderé, Arnaud and Traore, Eliezer and Zoungrana, Lassane and Zerbo, Béatrice and Sawadogo, Adrien Bruno and Zoungrana, Jacques and Héma, Arsène and Soré, Ibrahim and Bado, Guillaume and Tapsoba, Achille and Yé, Diarra and Kouéta, Fla and Ouedraogo, Sylvie and Ouédraogo, Rasmata and Hiembo, William and Gansonré, Mady and Messou, Eugene and Gnokoro, Joachim Charles and Koné, Mamadou and Kouakou, Guillaume Martial and Bosse, Clarisse Amani and Brou, Kouakou and Assi, Achi Isidore and Chenal, Henri and Hawerlander, Denise and Soppi, Franck and Abo, Yao and Bomisso, Germain and Eholie, Serge P and Amego, Mensah Deborah Noelly and Andavi, Viviane and Diallo, Zelica and Ello, Frédéric and Tanon, Aristophane Koffi and Koule, Serge Olivier and Anzan, Koffi Charles and Guehi, Calixte and Aka, Edmond Addi and Issouf, Koffi Ladji and Kouakou, Jean-Claude and N'Gbeche, Marie-Sylvie and Touré, Pety and Avit-Edi, Divine and Kouakou, Kouadio and Moh, Magloire and Yao, Valérie Andoblé and Folquet, Madeleine Amorissani and Dainguy, Marie-Evelyne and Kouakou, Cyrille and Méa-Assande, Véronique Tanoh and Oka-Berete, Gladys and Zobo, Nathalie and Acquah, Patrick and Kokora, Marie-Berthe and Eboua, Tanoh François and Timité-Konan, Marguerite and Ahoussou, Lucrèce Diecket and Assouan, Julie Kebé and Sami, Mabéa Flora and Kouadio, Clémence and Renner, Lorna and Goka, Bamenla and Welbeck, Jennifer and Sackey, Adziri and Owiafe, Seth Ntiri and Wejse, Christian and Da Silva, Zacarias José and Paulo, Joao and Rodrigues, Amabelia and Da Silva, David and ... and IeDEA West Africa Collaboration and IeDEA West Africa collaboration
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e66135
Background: HIV-2 is endemic in West Africa. There is a lack of evidence-based guidelines on the diagnosis, management and antiretroviral therapy (ART) for... 
HIV-2-INFECTED INDIVIDUALS | INTERNATIONAL COLLABORATION | RALTEGRAVIR | MULTIDISCIPLINARY SCIENCES | IMMUNOLOGICAL RESPONSE | INFECTION | DRUG-RESISTANCE | TYPE-1 HIV-1 | DIFFERENTIATION | INHIBITORS | TO-CHILD TRANSMISSION | Africa, Western - epidemiology | HIV-1 - isolation & purification | HIV-2 - isolation & purification | HIV Infections - virology | Humans | Middle Aged | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Male | Cohort Studies | Infection | Antiviral agents | Highly active antiretroviral therapy | Analysis | HIV (Viruses) | Health aspects | Evidence-based medicine | Epidemiology | Medical research | Antiretroviral drugs | Therapy | Clinical trials | Infections | Medical diagnosis | Patients | Antiretroviral therapy | CD4 antigen | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Collaboration | Adults | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Access to antiretroviral therapy in HIV-infected children aged 0–19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004–2015: A prospective cohort study
by Desmonde, Sophie and Tanser, Franck and Vreeman, Rachel and Takassi, Elom and Edmonds, Andrew and Lumbiganon, Pagakrong and Pinto, Jorge and Malateste, Karen and McGowan, Catherine and Kariminia, Azar and Yotebieng, Marcel and Dicko, Fatoumata and Yiannoutsos, Constantin and Mubiana-Mbewe, Mwangelwa and Wools-Kaloustian, Kara and Davies, Mary-Ann and Leroy, Valériane and Int Epidemiology Databases Evaluat and International Epidemiology Databases to Evaluate AIDS (IeDEA) Pediatric Working Group and for the International Epidemiology Databases to Evaluate AIDS (IeDEA) Pediatric Working Group
PLoS Medicine, ISSN 1549-1277, 05/2018, Volume 15, Issue 5, p. e1002565
Introduction Access to antiretroviral therapy (ART) is a global priority. However, the attrition across the continuum of care for HIV-infected children between... 
REGRESSION | AFRICA | MEDICINE, GENERAL & INTERNAL | TRANSMISSION | EARLY INFANT DIAGNOSIS | MISSED OPPORTUNITIES | DISCLOSURE | INITIATION | RETENTION | PREVENTION | ACCEPTABILITY | Health Services Accessibility - statistics & numerical data | Humans | Child, Preschool | Infant | Male | Young Adult | Anti-HIV Agents - supply & distribution | Time Factors | Adolescent | Global Health - statistics & numerical data | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Child | Infant, Newborn | Databases, Factual | Highly active antiretroviral therapy | Antiviral agents | Care and treatment | Databases | Analysis | AIDS (Disease) | HIV patients | Infants | HIV (Viruses) | Epidemiology | Patients | Continuum of care | Medical research | Distribution | Medicine, Experimental | HIV infection in children | Management | Drug therapy | Adolescence | Antiretroviral drugs | Therapy | Income | Data bases | Antiretroviral therapy | Incidence | Consortia | Missing data | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Teenagers | Diagnosis | Children | Adolescents | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Transition from paediatric to adult care of adolescents living with HIV in sub‐Saharan Africa: challenges, youth‐friendly models, and outcomes
by Dahourou, Désiré Lucien and Gautier‐Lafaye, Chloé and Teasdale, Chloe A and Renner, Lorna and Yotebieng, Marcel and Desmonde, Sophie and Ayaya, Samuel and Davies, Mary‐Ann and Leroy, Valériane
Journal of the International AIDS Society, ISSN 1758-2652, 05/2017, Volume 20, Issue Suppl 3, pp. 21528 - n/a
Introduction: The number of adolescents with perinatally or behaviourally acquired HIV is increasing in low‐income countries, and especially in sub‐Saharan... 
HIV infections | adolescents | youth | transition | Africa | Transition | Youth | Adolescents | YOUNG-ADULTS | INFECTIOUS DISEASES | COTE-DIVOIRE | RETENTION | IMMUNOLOGY | INFECTED ADOLESCENTS | POSITIVE ADOLESCENTS | DISCLOSURE | TREATMENT PROGRAMS | EXPERIENCE | ART INITIATION | ANTIRETROVIRAL TREATMENT | Africa, Eastern | Prevalence | HIV Infections - epidemiology | Humans | Models, Organizational | Transition to Adult Care | Male | Young Adult | Adolescent | HIV Infections - therapy | Female | Social Stigma | Africa South of the Sahara - epidemiology | Child | Antiviral agents | Care and treatment | Dosage and administration | HIV infection | Teenagers | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Costs of care of HIV-infected children initiating lopinavir/ritonavir-based antiretroviral therapy before the age of two in Cote D'Ivoire
by Desmonde, Sophie and Avit, Divine and Petit, Junie and Folquet, Madeleine Amorissani and Eboua, Francois Tanoh and Bosse, Clarisse Amani and Dainguy, Evelyne and Mea, Véronique and Timite-Konan, Marguerite and Ngbeché, Sylvie and Ciaranello, Andrea and Leroy, Valeriane
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0166466
Objectives To access the costs of care for Ivoirian children before and after initiating LPV/r-based anti-retroviral therapy (ART) before the age of two.... 
MORTALITY | ABIDJAN | RESOURCE-LIMITED SETTINGS | MORBIDITY | PROGRAMS | MULTIDISCIPLINARY SCIENCES | INFANTS | NEVIRAPINE | EFFICIENCY | Outcome Assessment (Health Care) - methods | Lost to Follow-Up | Prospective Studies | Follow-Up Studies | HIV Infections - economics | Humans | Cote d'Ivoire | Acquired Immunodeficiency Syndrome - prevention & control | Infant | Male | Survival Rate | Outcome Assessment (Health Care) - economics | Health Care Costs | Outcome Assessment (Health Care) - statistics & numerical data | Ritonavir - therapeutic use | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - mortality | Lopinavir - therapeutic use | Highly active antiretroviral therapy | Ritonavir | Analysis | Lopinavir | Economic aspects | Dosage and administration | Children | Drug therapy | Health aspects | HIV infection | Medical care, Cost of
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d’Ivoire
by Desmonde, Sophie and Avit, Divine and Petit, Junie and Amorissani Folquet, Madeleine and Eboua, Francois Tanoh and Amani Bosse, Clarisse and Dainguy, Evelyne and Mea, Véronique and Timite-Konan, Marguerite and Ngbeché, Sylvie and Ciaranello, Andrea and Leroy, Valeriane
PLOS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0166466
Objectives To access the costs of care for Ivoirian children before and after initiating LPV/r-based antiretroviral therapy (ART) before the age of two.... 
Drugs | Antiretroviral drugs | Therapy | Pediatrics | Costs | Drug delivery systems | Laboratories | Ritonavir | Medical practices | Lopinavir | Prophylaxis | Morbidity | Antiretroviral therapy | Confidence intervals | Hospitals | Tuberculosis | Antiretroviral agents | Human immunodeficiency virus--HIV | Cotrimoxazole | Children | Cost analysis | Drug therapy | Age | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers
by Desmonde, Sophie and Goetghebuer, Tessa and Thorne, Claire and Leroy, Valériane
Current Opinion in HIV and AIDS, ISSN 1746-630X, 09/2016, Volume 11, Issue 5, pp. 465 - 476
Purpose of review The number of HIV-exposed but uninfected (HEU) infants exposed to both HIV and multiple antiretroviral drugs in utero and during prolonged... 
mortality | health | infectious morbidity | HIV-exposed uninfected | child | BREAST-FEEDING DURATION | SOUTH-AFRICA | INFECTIOUS DISEASES | IN-UTERO EXPOSURE | ANTIRETROVIRAL THERAPY | BIRTH-DEFECTS | IMMUNOLOGY | CORD BLOOD-CELLS | TENOFOVIR DISOPROXIL FUMARATE | GROWTH OUTCOMES | INCREASED RISK | LANGUAGE OUTCOMES | HIV Infections | Maternal-Fetal Exchange | Humans | Breast Feeding | Child, Preschool | Infant | Pregnancy Complications, Infectious | Incidence | Pregnancy | Survival Analysis | Female | Child | Infant, Newborn
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: The MONOD ANRS 12206 non-inferiority randomised trial
by Dahourou, Désiré Lucien and Amorissani-Folquet, Madeleine and Malateste, Karen and Amani-Bosse, Clarisse and Coulibaly, Malik and Seguin-Devaux, Carole and Toni, Thomas and Ouédraogo, Rasmata and Blanche, Stéphane and Yonaba, Caroline and Eboua, François and Lepage, Philippe and Avit, Divine and Ouédraogo, Sylvie and Van de Perre, Philippe and N'Gbeche, Sylvie and Kalmogho, Angèle and Salamon, Roger and Meda, Nicolas and Timité-Konan, Marguerite and Leroy, Valériane and Désiré Lucien Dahourou, Lucien Dahourou and Colette Ouédraogo, Ouedraogo and Sawadogo, Mamadou and Wilfried Somé, Some and Désiré Sondo, Sondo and Thio, Elisabeth and Barry, Mamadou and Hiembo, William and Fla Kouéta, Koueta and Ouattara, Adama and Moussa Ouédraogo, Ouedraogo and Rasmata Ouédraogo, Ouedraogo and Sylvie Ouédraogo, Ouedraogo and Congo, Bernadette and Barry, Rose and Yé, Diarra and Congo, Malika and Edouard Minéné, Minene and Coulibaly, Marie and Angèle Kalmogho, Pierre Innocent Guissou and Kam, Ludovic and Emile Ouédraogo, Ouedraogo and Lassana Sangaré, Sangare and Tiendrebeogo, Sylvestre and Ky-Zerbo, Odette and Anglaret, Xavier and Clarisse Amani-Bossé, Amani-Bosse and Danel, Christine and Serge Eholié, Eholie and Didier Ekouévi, Ekouevi and Kanga, Eulalie and Kouadio, Suzanne and Lennaud, Séverin and Aimé Oga, Maxime and N'Dri-Yoman, Thérèse and Dainguy, Evelyne and Kouassi, Beugre and Kouassi, Jean-Claude and Gladys Oka, Oka and Keita, Kader and Lambin, Jean Yves and Tanoh, François Eboua and Aka, Addi Edmond and Aka-Dago, Hortense and Sylvie N'Gbeche, N'Gbeche and Messou, Eugène and Emieme, Arlette and Fatoumata Koné, Kone and Hervé Menan, Menan and Vincent Yapo, Yapo and Abo, Kouamé and Ahoba, Irma and Aka, David and Kodo, Carine and Siaka, Touré and Touré, Pety and Ekouevi, Fassinou and Viho, Ida and Tanoh, Anthony Richard and Olivier Blé, Ble and Koné, Berté and Dattez, Sophie and Desmonde, Sophie and Jesson, Julie and Karcher, Sophie and Jérôme Le Carrou, Le Carrou and Valériane Leroy, Leroy and Ndondoki, Camille and Touret, Pierre and Bouyssou, Caroline and Geneviève Chêne, Chene and Valérie Conte, Conte and Gabillard, Delphine and Valérie Journot, Journot and Devaux, Carole and Schmit, Jean-Claude and Stéphane Blanche, Blanche and Hirt, Deborah and Rouzioux, Christine and ... and MONOD Study Grp and MONOD Study Group
BMC Medicine, ISSN 1741-7015, 04/2017, Volume 15, Issue 1, p. 85
Background: The 2016 World Health Organization guidelines recommend all children <3 years start antiretroviral therapy (ART) on protease inhibitor-based... 
HIV | Protease inhibitors | Randomised clinical trial | Virological outcomes | Early antiretroviral treatment | Lopinavir | Africa | Treatment simplification | Infants | Efavirenz | MORTALITY | DIAGNOSIS | OPPORTUNITIES | NEVIRAPINE | PROTEASE INHIBITOR | MEDICINE, GENERAL & INTERNAL | 1ST-LINE ANTIRETROVIRAL THERAPY | RESISTANCE | EXPOSURE | Dideoxynucleosides - administration & dosage | HIV-1 | Lamivudine - administration & dosage | Benzoxazines - administration & dosage | Ritonavir - administration & dosage | HIV Infections - virology | Humans | Cote d'Ivoire | Child, Preschool | Genotype | Infant | Male | Treatment Outcome | Reverse Transcriptase Inhibitors - administration & dosage | Anti-HIV Agents - administration & dosage | Burkina Faso | Lopinavir - administration & dosage | Female | HIV Infections - drug therapy | Drug Therapy, Combination | Viral Load - drug effects | Drug Combinations | Infant, Newborn | Low income groups | Drugs | Antiretroviral drugs | Therapy | Simplification | Statistical analysis | Drug resistance | Statistical tests | Syrup | Antiretroviral therapy | Confidence intervals | Randomization | Tuberculosis | Protease | Human immunodeficiency virus--HIV | Mutation | Children | Refrigeration | Zidovudine | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Growth in the first 5 years after antiretroviral therapy initiation among HIV‐infected children in the IeDEA West African Pediatric Cohort
by Jesson, Julie and Ephoevi‐Ga, Ayoko and Desmonde, Sophie and Ake‐Assi, Marie‐Hélène and D'Almeida, Marcelline and Sy, Haby Signaté and Malateste, Karen and Amorissani‐Folquet, Madeleine and Dicko, Fatoumata and Kouadio, Kouakou and Renner, Lorna and Leroy, Valériane and Zannou, Marcel Djimon and Poda, Armel and Sarfo, Fred Stephen and Messou, Eugene and Chenal, Henri and Minga, Kla Albert and Bissagnene, Emmanuel and Tanon, Aristophane and Seydi, Moussa and Patassi, Akessiwe Akouda and Koumakpai‐Adeothy, Sikiratou Adouni and N'Gbeche, Sylvie Marie and Bosse, Clarisse Amani and Folquet, Madeleine Amorissani and Eboua, François Tanoh and Takassi, Elom and Dabis, François and Becquet, Renaud and Bernard, Charlotte and Arikawa, Shino Chassagne and Jaquet, Antoine and Rabourdin, Elodie and Tiendrebeogo, Thierry and Dahourou, Désiré and Ekouevi, Didier Koumavi and Azani, Jean‐Claude and Coffie, Patrick and Cissé, Abdoulaye and Gnepa, Guy and Horo, Apollinaire and Kouadio, Christian and Tchounga, Boris and IeDEA West African Pediatric Collaboration and the IeDEA West African Pediatric Collaboration
Tropical Medicine & International Health, ISSN 1360-2276, 06/2019, Volume 24, Issue 6, pp. 775 - 785
Summary Objective To describe growth evolution and its correlates in the first 5 years of antiretroviral therapy (ART) initiation among HIV‐infected children... 
malnutrition | HIV | VIH | antiretroviral therapy | croissance | growth | traitement antirétroviral | enfant | child | Highly active antiretroviral therapy | Antiviral agents | Pediatrics | Growth | Analysis | HIV patients | Children | HIV (Viruses) | HIV infection | Therapy | Anthropometry | Immunodeficiency | Cohorts | Weight | Girls | Antiretroviral therapy | Body height | Body mass | Antiretroviral agents | Correlation analysis | Human immunodeficiency virus--HIV | Evolution | Heat affected zone | Height | Malnutrition | Drug therapy | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Validation and calibration of a computer simulation model of pediatric HIV infection
by Ciaranello, Andrea L and Morris, Bethany L and Walensky, Rochelle P and Weinstein, Milton C and Ayaya, Samuel and Doherty, Kathleen and Leroy, Valeriane and Hou, Taige and Desmonde, Sophie and Lu, Zhigang and Noubary, Farzad and Patel, Kunjal and Ramirez-Avila, Lynn and Losina, Elena and Seage III, George R and Freedberg, Kenneth A
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e83389
Background: Computer simulation models can project long-term patient outcomes and inform health policy. We internally validated and then calibrated a model of... 
MORTALITY | COST-EFFECTIVENESS | ECONOMIC-EVALUATION | VIRUS-INFECTION | COTRIMOXAZOLE PROPHYLAXIS | COTE-DIVOIRE | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | INFANTS BORN | TO-CHILD TRANSMISSION | DISEASE PROGRESSION | Africa - epidemiology | Models, Biological | Computer Simulation | Humans | Adolescent | Child, Preschool | Female | HIV Infections - mortality | HIV Infections - transmission | Infant | Male | Child | Medical policy | Pediatrics | Antiviral agents | Care and treatment | Computer simulation | AIDS treatment | Mortality | HIV (Viruses) | Diseases | Prevention | Highly active antiretroviral therapy | Computer-generated environments | Analysis | Children | HIV infection | Opportunist infection | Infants | Infections | Birth | Parameter identification | Epidemiology | Health policy | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Mathematical models | Monte Carlo method | Antiretroviral drugs | Complications | Health risks | Calibration | Survival | Empirical analysis | Antiretroviral therapy | CD4 antigen | Simulation | Womens health | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Genotypic resistance profiles of HIV-2-treated patients in West Africa
by Charpentier, Charlotte and Charpentier, Charlotte and Eholié, Serge and Eholié, Serge and Anglaret, Xavier and Anglaret, Xavier and Bertine, Mélanie and Bertine, Mélanie and Rouzioux, Christine and Rouzioux, Christine and Avettand-Fenoël, Véronique and Avettand-Fenoël, Véronique and Messou, Eugène and Messou, Eugène and Minga, Albert and Minga, Albert and Damond, Florence and Damond, Florence and Plantier, Jean-Christophe and Plantier, Jean-Christophe and Dabis, François and Dabis, François and Peytavin, Gilles and Peytavin, Gilles and Brun-Vézinet, Françoise and Brun-Vézinet, Françoise and Ekouevi, Didier K and Ekouevi, Didier K and Bissagnene, Emmanuel and Arrivé, Elise and Coffie, Patrick and Jaquet, Antoine and Leroy, Valériane and Lewden, Charlotte and Sasco, Annie J and Zannou, Djimon Marcel and Ahouada, Carin and Akakpo, Jocelyn and Ahomadegbé, Christelle and Bashi, Jules and Gougounon-Houéto, Alice and Azon-Kouanou, Angèle and Houngbé, Fabien and Sehonou, Jean and Koumakpaï, Sikiratou and Alihonou, Florence and D'Almeida, Marcelline and Hodonou, Irvine and Hounhoui, Ghislaine and Sagbo, Gracien and Tossa-Bagnan, Leïla and Adjide, Herman and Drabo, Joseph and Bognounou, René and Dienderé, Arnaud and Traore, Eliezer and Zoungrana, Lassane and Zerbo, Béatrice and Sawadogo, Adrien Bruno and Zoungrana, Jacques and Héma, Arsène and Soré, Ibrahim and Bado, Guillaume and Tapsoba, Achille and Yé, Diarra and Kouéta, Fla and Ouedraogo, Sylvie and Ouédraogo, Rasmata and Hiembo, William and Gansonré, Mady and Gnokoro, Joachim Charles and Koné, Mamadou and Kouakou, Guillaume Martial and Bosse, Clarisse Amani and Brou, Kouakou and Assi, Achi Isidore and Chenal, Henri and Hawerlander, Denise and Soppi, Franck and Abo, Yao and Yoboue, Jean-Michel and Eholié, Serge Paul and Amego, Mensah Deborah Noelly and Andavi, Viviane and Diallo, Zelica and Ello, Frédéric and Tanon, Aristophane Koffi and Koule, Serge Olivier and Anzan, Koffi Charles and Guehi, Calixte and Aka, Edmond Addi and Issouf, Koffi Ladji and Kouakou, Jean-Claude and N'Gbeche, Marie-Sylvie and Pety, Touré and Avit-Edi, Divine and Kouakou, Kouadio and Moh, Magloire and Yao, Valérie Andoblé and Folquet, Madeleine Amorissani and ... and IeDEA West Africa Collaboration
AIDS, ISSN 0269-9370, 2014, Volume 28, Issue 8, pp. 1161 - 1169
Objective: To assess the virological response, genotypic resistance profiles, and antiretroviral plasma concentrations in HIV-2 antiretroviral-treated... 
Côte d'Ivoire | HIV-2 | Plasma drug concentrations | Antiretroviral resistance | VIRAL LOAD | INFECTIOUS DISEASES | Cote d'Ivoire | IMMUNOLOGY | PROTEASE INHIBITORS | HIV-2-INFECTED PATIENTS | SENEGAL IMPLICATIONS | IN-VITRO | antiretroviral resistance | REVERSE-TRANSCRIPTASE INHIBITORS | VIROLOGY | VITRO PHENOTYPIC SUSCEPTIBILITY | plasma drug concentrations | ANTIRETROVIRAL DRUG-RESISTANCE | HIV-2 INFECTION | IMMUNODEFICIENCY-VIRUS TYPE-2 | Anti-Retroviral Agents - therapeutic use | Cross-Sectional Studies | HIV Infections - genetics | Humans | Middle Aged | Genotype | Male | Treatment Outcome | Mutation - genetics | Viral Load | Sequence Analysis, RNA - methods | Drug Resistance, Viral - genetics | Adult | Female | HIV Infections - drug therapy | HIV-2 - genetics | Anti-Retroviral Agents - blood | Patient Compliance | Chromatography, Liquid - methods | Tandem Mass Spectrometry - methods | Côte d’Ivoire
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009
by Desmonde, Sophie and Coffie, Patrick and Aka, Edmond and Amani-Bosse, Clarisse and Messou, Eugène and Dabis, François and Alioum, Ahmadou and Ciaranello, Andrea and Leroy, Valériane
BMC Infectious Diseases, ISSN 1471-2334, 06/2011, Volume 11, Issue 1, pp. 182 - 182
Background: Clinical evolution of HIV-infected children who have not yet initiated antiretroviral treatment (ART) is poorly understood in Africa. We describe... 
INFECTIOUS DISEASES | COST-EFFECTIVENESS | TRANSMISSION | 1ST 2 YEARS | COTRIMOXAZOLE | RISK | ANTIRETROVIRAL THERAPY | HIV-1-INFECTED CHILDREN | INFANTS BORN | NATURAL-HISTORY | SCALING-UP | Prospective Studies | HIV Infections - epidemiology | Humans | Mortality | Child, Preschool | Infant | Male | Cote d'Ivoire - epidemiology | Morbidity | Pediatrics - statistics & numerical data | Adolescent | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy |